Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Daratumumab 1800 / Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 40, multiple myeloma, induction, cycle 1-2

Protocol-ID: 2516 V1.0 (Mini), DRTM1800/BORT1.3/LENA25/DEXA40, MM, Ind., C1-2

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 03.05.2024